共 43 条
- [21] Letter to the Editor concerning “Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study” by Fischgrund JS, et al. [Eur Spine J; (2018) 27(5): 1146–1156] European Spine Journal, 2019, 28 : 2223 - 2223
- [22] Answer to the letter to the editor of Y. Li et al. concerning “Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study” by Fischgrund JS, et al. [Eur Spine J; (2018) 27(5): 1146–1156] European Spine Journal, 2019, 28 : 2224 - 2224
- [23] Letter to the Editor concerning "Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study" by Fischgrund JS']JS, et al. [Eur Spine J; (2018) 27(5): 1146-1156] EUROPEAN SPINE JOURNAL, 2019, 28 (09) : 2223 - 2223
- [24] Answer to the letter to the editor of Y. Li et al. concerning "Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study" by Fischgrund JS']JS, et al. [Eur Spine J; (2018) 27(5): 1146-1156] EUROPEAN SPINE JOURNAL, 2019, 28 (09) : 2224 - 2224
- [27] Probiotics for chronic low back pain with type 1 Modic changes: a randomized double-blind, placebo-controlled trial with 1-year follow-up using Lactobacillus Rhamnosis GG European Spine Journal, 2019, 28 : 2478 - 2486
- [30] Answer to the Letter to the Editor of Miao Yu et al. concerning "Is L5-S1 motion segment different from the rest? A radiographic kinematic assessment of 72 patients with chronic low back pain" by AB Sabnis et al. (Eur. Spine J; 27(5):1127-1135) EUROPEAN SPINE JOURNAL, 2019, 28 (05) : 1249 - 1249